Endometrial Cancer Eisai Contributes to the Science of Cancer Medicine at ASCO 2022By adminMay 30, 20220 Data on Farletuzumab Ecteribulin (MORAb-202) Showcase Eisai’s Advanced Chemistry Capabilities and Commitment to Identifying Novel Approaches in Treating Cancer to…
